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Abstract
Introduction: Infections are the most frequent and severe complications of acute necrotizing pancreatitis with a
mortality rate of up to 80 percent. Although experimental and clinical studies suggest that the microbiologic
source of pancreatic infection could be enteric, information in this regard is controversial.
Case presentation: We describe a Citrobacter freundii isolation by endoscopy ultrasound fine needle aspiration in a
80-year-old Caucasian man with pancreatic pseudocyst after acute necrotizing pancreatitis.
Conclusion: Our case report confirms that this organism can be recovered in patients with a pancreatic
pseudocyst. On-site cytology feedback was crucial to the successful outcome of this case as immediate
interpretation of the fine needle aspiration sample directed the appropriate cultures and, ultimately, the curative
therapy. To the best of our knowledge, this is the first reported case of isolated pancreatic C. freundii diagnosed by
endoscopy ultrasound fine needle aspiration.
Introduction
The infection of pancreatic and peripancreatic tissue in
the course of severe acute pancreatitis (AP) occurs most
frequently in patients with extensive pancreatic necrosis.
Pancreatic pseudocysts are fluid collections that do not
resolve, often communicative with the pancreatic ductal
system, and slowly develop a circumferential capsule.
They should be differentiated from the early extrava-
sated fluid collections, having a dissimilar clinical signifi-
cance and requiring a different therapeutic approach [1].
The species of pathogens isolated from an infected pan-
creas suggest an enteric origin in both pancreatic cyst
and infected pancreatic necrosis. Nevertheless, the origin
and route of the bacteria leading to infection of the
pancreatic gland in AP are still unclear. Several mechan-
isms have been proposed to explain how these enteric
bacteria reach the pancreas: translocation of bacteria
from the gut, infection from the biliary tree or duode-
num, as well as hematogenous or lymphatic spread from
other sites. The most commonly isolated
microorganisms in pancreatic infections are E. coli,
Enterococcus spp., Klebsiella pneumonidae and, Entero-
bacter spp.; less frequent are Staphylococcus spp., Pseu-
domonas aeruginosa, Streptococcus spp., and Bacteroides
[2].
Members of genus Citrobacter are Gram-negative,
non-spore-forming rods belonging to the family Entero-
bacteriaceae and, as the name suggests, usually utilize
citrate as a sole carbon source. These facultative anae-
robes typically are motile by means of peritrichous fla-
gella. They ferment glucose and other carbohydrates
with the productions of acid and gas. They are oxidase
negative, catalase and methyl red positive, Voges-
Proskauer negative, and do not decarboxylate lysine.
They are differentiated by their ability to convert trypto-
phan to indole. Of the dozen species, C. freundii,
C. diversus,a n dC. amalonaticus are linked to human
disease [3]. Acute necrotizing pancreatitis associated
with Citrobacter infections is rare, and up to now, few
cases have been reported in the literature.
Case presentation
A 80-year-old Caucasian man presented to our hospital
with acute right lower quadrant and periumbilical
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abuse, cholelithiasis, abdominal trauma or surgery, nor
ingestion of raw food or medications. On admission,
hematological tests revealed normal hematocrit and pla-
telet counts, and an increased white blood cell count of
23,800 mm
-3 (reference range: 4,000 to 10,000 mm
-3)
with 37.8% lymphocytes. The biochemical test results
were within the reference range: ALT: 11 U/L (0 to 35),
AST: 12 (0 to 35), glucose: 123, urea: 49, and creatinine:
1 , 1 ,N a :1 4 2 ,K :4 . 9 ,a n ds e r u ma m y l a s e :3 1 5 7U I / L( 1 0
to 110). A computed tomographic (CT) abdominal scan
was performed revealing necrosis over 30% of the pan-
creas and the presence of liquid in the peripancreatic
cavity (Figure 1). With this finding, it was decided to
perform an endoscopic ultrasound. The pancreatic par-
enchyma showed a slightly abnormally structured and
irregular mass-like aspect on the head, compatible with
an inflammatory process. The pancreatic body reflected
a homogeneous pattern with an irregular and slightly
dilated main pancreatic duct. In the neck of the pan-
creas, a cystic lesion with a dense aspect of 42.2 × 35.1
mm was revealed, probably related to a pseudocystic
versus postnecrotic cavity. A gallbladder with hypere-
chogenic foci without an acoustic shadow floating
inside, which is compatible with microlithiasis, was
described. Endoscopy ultrasound fine needle aspiration
(EUS-FNA; by using lineal equipment and a 22G needle
puncture) was performed over the injury in the pancrea-
tic head (Figure 2). Samples obtained were submitted
for cytohistological and microbiological evaluation.
Pathology results showed small fragments of pancreatic
parenchyma without evidence of malignancy surrounded
by areas of necrosis and inflammation. Microbiological
analysis reveals a monoculture isolating Citrobacter
freundii by biochemical testing with an API 20E system
(API Biomerieux SA, Marcy I’Etoile, France yielded the
numerical code 1604572 for the isolate. According to
the API 20E database, this represented a “very good
identification” for C. freundii. An analysis using
16SrRNA gene by PCR-Sequencing method was per-
formed to confirm the pathogen identity. 16SrRNA gene
of strain and Citrobacter freundii (FN997639) has the
nearest kinship and are located in the same phylogenetic
tree.
Experiments with this bacterium in cell lines (cyto-
pathic effect) and rats (i.p. injection) were performed
and showed vacuolization of the cells as well as develop-
ment of acute pancreatitis in the rats, demonstrating
high levels of virulence of the strain. Susceptibility test-
ing showed intermediate susceptibility to cefuroxim,
although it was completely susceptible to ciprofloxacin.
Oral ciprofloxacine (500 mg × 2) was administrated
over six weeks. During treatment our patient progressed
satisfactorily. A week after starting the treatment, he felt
well and the abdominal pain gradually decreased. With
the diagnosis of an acute necrotizing pancreatitis com-
plicated with a pseudocystic percutaneous, he was dis-
charged and referred to our Pancreatobiliary Unit. An
abdominal ultrasound (Figure 3) performed six months
later revealed a complete resolution of the previous
inflammatory process.
Figure 1 Computed tomographic abdominal scan (CT) showing
necrosis and presence of liquid in peripancreatic cavity.
Figure 2 Endoscopic ultrasound-guided fine needle aspiration
of the pancreatic mass.
Figure 3 Abdominal ultrasound showing the normal pancreas
six months after the episode.
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In this study, Citrobacter freundii was detected in a
sample obtained by EUS-FNA of a patient with pancrea-
tic pseudocyst after an acute necrotizing pancreatitis.
EUS-FNA has emerged as an excellent tool to both
image and sample pancreatic lesions [1]. It is considered
the most sensitive and specific method of identifying
pancreatic masses. The American Joint Commission on
Cancer recommends EUS-FNA as the preferred diagnos-
tic modality for pancreatic masses [2]. The presence of
an on-site cytologist for immediate interpretation is a
common practice in most high volume EUS centers [3].
On-site cytologic evaluation has been shown to increase
the diagnostic yield by 10 to 15% [4-6] and can decrease
procedure time and potential complications through
avoidance of unnecessary needle passes once diagnostic
tissue is obtained.
Most pathogens in pancreatic infection are gastroin-
testinal Gram negative bacteria; the colon seems to be
the main source of pancreatitis related infections. There-
fore, it is possible that bacterial translocation (BT) is the
most important mechanism for contamination of
pancreatic necrosis.
Pancreatic pseudocysts are more frequently polymicro-
bial (57%) than monomicrobial (43%). This fact con-
trasts with infected necrosis, where monomicrobial
infections are usually found. Up to now anaerobes and
fungi have rarely been reported; however, the bacterial
spectrum may change in the near future due to the use
of specific antibiotics leading to an increase in different
microorganisms, especially fungi [2].
The diagnosis of pancreatic pseudocyst is based on
clinical suspicion, imaging techniques, and demonstra-
tion of infection. Since clinical presentation may be very
variable, pancreatic infection should be suspected in any
patient with fever or suggestive signs or symptoms of
sepsis within the context of AP. Once pancreatic pseu-
docysts have been diagnosed the treatment is complete
drainage. Pancreatic pseudocysts do not resolve sponta-
n e o u s l ya n d ,i fu n t r e a t e d ,t h ep r o g n o s i sf o rap a t i e n ti s
almost invariably death. Currently, two different
approaches can be considered for primary drainage of a
pancreatic pseudocyst: surgical and percutaneous.
Appropriate antibiotic therapy depends on the identifi-
cation of the causative microorganisms and sensitivity
testing. Meanwhile, several options have been recom-
mended: a combination of ceftazidime and clindamycin;
a combination of ciprofloxacin and metronidazole; or
carbapenems as a single agent due to its extremely
broad spectrum of activity [2].
Several trials have assessed the frequency of bacterial
infection of necrotic areas in the natural course of
severe AP without antibiotic intervention [7]. Results
indicated an overall contamination rate of 24% within
the first week of the onset of AP, increasing to 46 and
71%, respectively, in the second and third week.
Escherichia fergusonii was isolated from pancreatic
carcinoma and cholangiosepsis [8] in a patient with a
history of weight loss, jaundice, and acholic stools. After
one day, E. fergusonii was grown as a single organism
from the gallbladder fluid as well as from blood culture.
M a n yo t h e rb a c t e r i ah a v eb e e ni n v o l v e di nA P[ 9 ] .
A case of AP associated with brucellosis was reported in
a 56-year-old patient with a seven-day history of fever,
generalized myalgia and arthralgia, lower back pain,
anorexia, and sweating. He experienced a sudden onset
of abdominal pain accompanied by nausea and vomiting.
He lived in an area of northwestern Greece where bru-
cellosis is endemic. The CT scan revealed the presence
of mild swelling of the pancreas without additional
abnormality. The Brucella agglutinins were present in a
titer and the blood culture grew B. maletiensis after
eight days of incubation.
Also, Mycobacterium tuberculosis w a si s o l a t e df r o ma
woman with a pancreatic mass. She was subsequently
diagnosed with pancreatic tuberculosis via EUS-
FNA. Intraprocedural immediate cytologic evaluation
prompted samples to be sent for appropriate microbio-
logical culture [10].
Studies evaluating the presence of bactDNA in biolo-
gical fluids of patients with AP and other pathologies
have rarely been reported in the literature. Madaria,
et al. [11] reported the presence of Citrobacter freundii
DNA and other pathogens (Pseudomona aeruginosa and
E. coli) in four blood samples from patients with
pancreatitis in Spain. There is no information in the lit-
erature regarding the pathogenic role of C. freundii in
the development of infections in patients with AP; this
bacterium has been shown to translocate in different
experimental and clinical situations and is related to
both biliary and intra-abdominal infections [12-14].
Enteric bacterial pathogens including Vibrio cholerae
and enterotoxigenic Escheriachia coli often produce
ADP-ribosylating enterotoxins that are mainly responsi-
ble for diarrheal diseases. Two well-characterized entero-
toxins, cholera toxins produced by toxigenic strains of
Vibrio cholerae and the heat-labile toxin (LT) produced
by enterotoxigenic E. coli (ETEC) strains, have been
detected to be virulence-like factors in Citrobacter freun-
dii using immunological methods and PCR [15-17]. This
suggests a possible gene transfer between C. freundii and
this species [18].
One of the virulence factors attributed to Citrobacter
spp. is the activation of transcription factors, kappa beta
(NFb), concretely in C. rodentium (previously C. freundii
biotype 4280). The NFb is a nuclear transcription which
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are critical for the regulation of apoptosis, viral replication,
tumorigenesis, inflammation, and various autoimmune
diseases. The NFb can be activated via different path-
ways. The most common, called the classical pathway, is
triggered in response to microbial or pro-inflammatory
cytokine injury, leading to a recruitment and activation of
the Ib-kinase (IK) complex which includes the scaffold
protein NFb essential modulator, NEMO, also named,
IKg [19-21].
It is possible that in pancreatic infections, NFb may
have an additional role to perform, for example, in the
expression and production of pro-inflammatory cyto-
quines during C. freundii infection and possibly in bac-
terial clearance.
Conclusion
The patient’s progress has been favorable. Final diagno-
sis isolated C. freundii based on a positive culture of an
EUS-FNA sample. On-site cytology feedback was crucial
to the successful outcome of this case as immediate
interpretation of the FNA sample directed us to the
appropriate cultures and, ultimately, the curative ther-
apy. To our knowledge, this is the first reported case of
isolated pancreatic C. freundii diagnosed by EUS-FNA.
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